SCHEMBL27925152

SCHEMBL27925152

O=C(O)C1(O)CCC(NCCc2ccccc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.62
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
OPRM1 P35372 2/20 0.56
OPRL1 P41146 2/20 0.56
GRIN2B Q13224 7/20 0.55
DRD4 P21917 1/20 0.48
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
EPHX1 P07099 2/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
EPHX2 P34913 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GRIN1 Q05586 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
CCR2 P41597 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL572229 0.85 OPRM1 (0.55) MEN1KMT2AOPRM1OPRL1GRIN2B
Hydrochloric Acid SCHEMBL573397 0.84 OPRM1 (0.56) MEN1KMT2AOPRM1OPRL1GRIN2B
SCHEMBL662411 0.79 GRIN2B (0.76) TAAR1MEN1KMT2AOPRM1OPRL1
SCHEMBL3760581 0.76 TAAR1 (0.75) TAAR1MEN1KMT2AOPRM1OPRL1
SCHEMBL3907332 0.76 TAAR1 (0.81) TAAR1MEN1KMT2AOPRM1OPRL1
SCHEMBL8949095 0.75 TAAR1 (0.61) TAAR1MEN1KMT2AOPRM1OPRL1
SCHEMBL24767088 0.74 TAAR1 (0.84) TAAR1MEN1KMT2AOPRM1OPRL1
SCHEMBL25002632 0.74 TAAR1 (0.84) TAAR1MEN1KMT2AOPRM1OPRL1
SCHEMBL21792273 0.74 TAAR1 (0.84) TAAR1MEN1KMT2AOPRM1OPRL1
SCHEMBL22216853 0.74 TAAR1 (0.84) TAAR1MEN1KMT2AOPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103168032-A Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase AMGEN INC 2013-06-19 CN disclosed